Literature DB >> 10826487

Analysis of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults.

G Becker-Pergola1, P Kataaha, L Johnston-Dow, S Fung, J B Jackson, S H Eshleman.   

Abstract

We analyzed plasma HIV-1 from 27 antiretroviral drug-naive Ugandan adults. Previous subtype analysis of env and gag sequences from these samples identified subtypes A, C, D, and recombinant HIV-1. Sequences of HIV-1 protease and reverse transcriptase (RT) were obtained with a commercial HIV-1 genotyping system. Subtypes based on protease sequences differed from gag subtypes for 5 of 27 samples, demonstrating a high rate of recombination between the gag and pol regions. Protease and RT sequences were analyzed for the presence of amino acid polymorphisms at positions that are sites of previously characterized drug resistance mutations. At those sites, frequent polymorphisms were detected at positions 36 and 69 in protease and positions 179, 211, and 214 in RT. Subtype-specific amino acid motifs were identified in protease. Most of the subtype A sequences had the amino acids DKKM at positions 35, 57, 69, and 89, whereas most subtype D sequences had the amino acids ERHL at those positions. Detection of those polymorphisms may provide a useful approach for rapid identification of subtype A and D isolates in Uganda. This analysis significantly increases the number of Ugandan protease and RT sequences characterized to date and demonstrates successful use of a commercial HIV-1 genotyping system for analysis of diverse non-B HIV-1 subtypes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10826487     DOI: 10.1089/088922200308800

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  15 in total

1.  Identification of Ugandan HIV type 1 variants with unique patterns of recombination in pol involving subtypes A and D.

Authors:  Susan H Eshleman; Matthew J Gonzales; Graziella Becker-Pergola; Shawn C Cunningham; Laura A Guay; J Brooks Jackson; Robert W Shafer
Journal:  AIDS Res Hum Retroviruses       Date:  2002-05-01       Impact factor: 2.205

2.  Catalytic efficiency and vitality of HIV-1 proteases from African viral subtypes.

Authors:  A Velazquez-Campoy; M J Todd; S Vega; E Freire
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

3.  A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.

Authors:  Robert W Shafer; Kathryn Dupnik; Mark A Winters; Susan H Eshleman
Journal:  HIV Seq Compend       Date:  2001

4.  Frequency of drug-resistant variants of HIV-1 coexistent with wild-type in treatment-naive patients of India.

Authors:  Naresh Sachdeva; Shobha Sehgal; Sunil K Arora
Journal:  MedGenMed       Date:  2005-07-27

5.  Active-site mutations in the South african human immunodeficiency virus type 1 subtype C protease have a significant impact on clinical inhibitor binding: kinetic and thermodynamic study.

Authors:  Salerwe Mosebi; Lynn Morris; Heini W Dirr; Yasien Sayed
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

6.  Use of sequence data generated in the Bayer Tru Gene genotyping assay to recognize and characterize non-subtype-b human immunodeficiency virus type 1 strains.

Authors:  Diane L Hirigoyen; Charles P Cartwright
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

7.  Genotypic and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART.

Authors:  E Caride; K Hertogs; B Larder; P Dehertogh; R Brindeiro; E Machado; C A de Sá; W A Eyer-Silva; F S Sion; L F Passioni; J A Menezes; A R Calazans; A Tanuri
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

8.  Performance of Applied Biosystems ViroSeq HIV-1 Genotyping System for sequence-based analysis of non-subtype B human immunodeficiency virus type 1 from Uganda.

Authors:  M Mracna; G Becker-Pergola; J Dileanis; L A Guay; S Cunningham; J B Jackson; S H Eshleman
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

9.  Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda.

Authors:  Susan H Eshleman; Oliver Laeyendecker; Neil Parkin; Wei Huang; Colombe Chappey; Agnes C Paquet; David Serwadda; Steven J Reynolds; Noah Kiwanuka; Thomas C Quinn; Ronald Gray; Maria Wawer
Journal:  AIDS       Date:  2009-04-27       Impact factor: 4.177

10.  Frequency of Drug-Resistant Variants of HIV-1 Coexistent With Wild-Type in Treatment-Naive Patients of India.

Authors:  Naresh Sachdeva; Shobha Sehgal; Sunil K Arora
Journal:  J Int AIDS Soc       Date:  2005-07-27       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.